NO951061L - Antistoffkonjugater med forbedrede egenskaper - Google Patents
Antistoffkonjugater med forbedrede egenskaperInfo
- Publication number
- NO951061L NO951061L NO951061A NO951061A NO951061L NO 951061 L NO951061 L NO 951061L NO 951061 A NO951061 A NO 951061A NO 951061 A NO951061 A NO 951061A NO 951061 L NO951061 L NO 951061L
- Authority
- NO
- Norway
- Prior art keywords
- improved properties
- antibody conjugates
- conjugate
- mammal
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94810173 | 1994-03-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951061D0 NO951061D0 (no) | 1995-03-20 |
| NO951061L true NO951061L (no) | 1995-09-22 |
Family
ID=8218230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951061A NO951061L (no) | 1994-03-21 | 1995-03-20 | Antistoffkonjugater med forbedrede egenskaper |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPH0820545A (ru) |
| KR (1) | KR950031111A (ru) |
| AU (1) | AU1481795A (ru) |
| CA (1) | CA2144936A1 (ru) |
| FI (1) | FI951276A (ru) |
| HU (1) | HUT71776A (ru) |
| IL (1) | IL113022A (ru) |
| NO (1) | NO951061L (ru) |
| NZ (1) | NZ270734A (ru) |
| RU (1) | RU95104325A (ru) |
| ZA (1) | ZA952269B (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865737B1 (fr) * | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
-
1995
- 1995-02-24 HU HU9500586A patent/HUT71776A/hu unknown
- 1995-03-14 AU AU14817/95A patent/AU1481795A/en not_active Abandoned
- 1995-03-17 FI FI951276A patent/FI951276A/fi unknown
- 1995-03-17 IL IL11302295A patent/IL113022A/xx not_active IP Right Cessation
- 1995-03-17 JP JP7059022A patent/JPH0820545A/ja active Pending
- 1995-03-17 NZ NZ270734A patent/NZ270734A/en unknown
- 1995-03-17 RU RU95104325/14A patent/RU95104325A/ru unknown
- 1995-03-17 CA CA002144936A patent/CA2144936A1/en not_active Abandoned
- 1995-03-20 ZA ZA952269A patent/ZA952269B/xx unknown
- 1995-03-20 NO NO951061A patent/NO951061L/no unknown
- 1995-03-20 KR KR1019950005739A patent/KR950031111A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT71776A (en) | 1996-01-29 |
| JPH0820545A (ja) | 1996-01-23 |
| NZ270734A (en) | 1997-05-26 |
| FI951276A (fi) | 1995-09-22 |
| ZA952269B (en) | 1995-09-21 |
| NO951061D0 (no) | 1995-03-20 |
| AU1481795A (en) | 1995-09-28 |
| KR950031111A (ko) | 1995-12-18 |
| CA2144936A1 (en) | 1995-09-22 |
| FI951276A0 (fi) | 1995-03-17 |
| IL113022A (en) | 2000-02-29 |
| HU9500586D0 (en) | 1995-04-28 |
| RU95104325A (ru) | 1996-12-27 |
| IL113022A0 (en) | 1995-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1135498E (pt) | Variantes de anticorpos com maior afinidade de ligação em comparação com os anticorpos parentais | |
| DK499086D0 (da) | Konjugater af trichothecen og anvendelse af samme som terapeutisk substans | |
| CO4850562A1 (es) | Proceso para producir una preparacion concentrada de anticuerpos | |
| MXPA02007756A (es) | Anticuerpos que aglutinan interleuqina-18 humana y metodos de fabricacion y uso. | |
| ATE383430T1 (de) | Rekombinante antikörper und immunkonjugate gezielt auf cd22-tragende zellen und tumoren | |
| PL248202A1 (en) | Process for preparing conjugate with chain b of toxin and method of manufacture of cytotoxic composition | |
| NO984136D0 (no) | Humanisert kimært antistoffmolekyl for bruk som dianostikum, og diagnostisk preparat omfattende et slikt antistoffmolekyl | |
| DE69729283D1 (de) | GLYKOSYLIERTE IgG ANTIKÖRPER | |
| EP0683234A4 (en) | ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE. | |
| AU1250483A (en) | Conjugate of enzyme and antibody | |
| EP4378958A3 (en) | High-affinity anti-mertk antibodies and uses thereof | |
| AU628948B2 (en) | Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof | |
| DK0969873T3 (da) | Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf | |
| IS4922A (is) | Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun | |
| EP0350690A3 (de) | Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente | |
| PT97423A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo conjugados de anticorpos para o tratamento de neoplasias | |
| DE69328779D1 (de) | Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden | |
| NO951061L (no) | Antistoffkonjugater med forbedrede egenskaper | |
| DE69611037D1 (de) | Methadonderivate und protein- und polypeptid-methadonkonjugate und markierte verbindungen | |
| Fodstad et al. | New indirect approach to the therapeutic use of immunotoxins | |
| IL139571A0 (en) | A humanized antibody that binds to verotoxin, methods for the production thereof and pharmaceutical compositions containing the same | |
| AU3637195A (en) | Broadly reactive opsonic antibodies reactive with common staphylococcal antigens | |
| DK0513565T3 (da) | Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse | |
| DK0889907T3 (da) | Monoklonale antistoffer, som binder humant væksthormon (hGH) | |
| JPH0469345A (ja) | 腫瘍細胞の除去方法 |